Four Case Western Reserve faulty recently secured state funding to help them move their research from the campus into the marketplace. The state funding of more than $300,000 comes from the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) https://development.ohio.gov/bs_thirdfrontier/tvsf.htm and the State I-Corps@Ohio program https://fisher.osu.edu/centers/tec/i-corps-at-ohio.
The TVSF awards provide funding to move technology toward commercialization through testing and prototyping. The goal is to help researchers license the technology through start-up and early stage companies. The I-Corps@Ohio program provides hands-on-training to faculty and graduate students to help them understand the technology commercialization process and the market potential for their technologies.
Pallavi Tiwari, Assistant Professor of Biomedical Engineering has developed NeuroRadVision, an imaging software that distinguishes between a recurrent brain tumor and benign effects of radiation which can appear similar on a routine MRI scan, resulting in unnecessary surgeries. Researchers estimate that 30,000 unnecessary brain surgeries are performed annually in the U.S and more than 100,000 worldwide.
An Associate Professor of Anesthesiology, James D. Reynolds, and Chair of the Anesthesiology Department James R. Rowbottom have developed a port sterilizer to reduce the number of catheter-related bloodstream infections. The team developed a sterile strip dispenser that clips over the injection port. The device eliminates the need for manually swabbing the port before each use.
Miklos Gratzi Biomedical Engineering Associate Professor, is developing a low cost handheld device to diagnose Cystic Fibrosis (CF), an inherited disease characterized by the buildup of mucus that can damage many of the body’s organs. CF’s most common symptoms include gradual damage to the respiratory system and chronic digestive system problems.
Current testing methods for CF use an infant’s sweat. However, about 20 percent of infants younger than 3 months old can’t produce enough swear to test accurately. Gratzi’s design uses much smaller samples of sweat which is about 85 percent less than current methods which can be obtained even from two week old babies.
To learn more contact Stephanie Weidenbecher in the Technology Transfer Office at saw43@case.edu or call 216-368-6191.